Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAVEN
ISRCTN79334891Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Dec 2020
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of hydroxychloroquine in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and 1 more, sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Percentage of patients with uncontrolled ANCA-associated vasculitis disease activity. Started Dec 2020; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)granulomatosis with polyangiitis (GPA)microscopic polyangiitis (MPA)eosinophilic granulomatosis with polyangiitis (EGPA)
Beyond the preview
Go deeper on ISRCTN79334891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN79334891.